Cargando…

Early Major Adverse Cardiovascular Event in a Patient With Chronic Kidney Disease: A Case Report

Acute coronary syndrome (ACS) is common in people with chronic kidney disease (CKD) and is linked to poor short- and long-term outcomes. The diagnosis of myocardial infarction is challenging in patients with CKD as they have baseline elevated troponin levels. To date, there are no widely accepted gu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saleh Juman Alseiari, Saleh, Fadil Ali Al Thehli, Reem, Farooq, Munawar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329737/ https://www.ncbi.nlm.nih.gov/pubmed/37431350 http://dx.doi.org/10.7759/cureus.40161

Ejemplares similares

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Major Adverse Cardiovascular Events: An Inevitable Outcome of ST-elevation myocardial infarction? A Literature Review
por: Poudel, Ishan, et al.
Publicado: (2019)

Effect of the index of cardiac electrophysiological balance on major adverse cardiovascular events in patients with diabetes complicated with coronary heart disease
por: Lin, Yuan, et al.
Publicado: (2023)

Elevated serum FGF21 predicts the major adverse cardiovascular events in STEMI patients after emergency percutaneous coronary intervention
por: Gu, Lingyun, et al.
Publicado: (2021)

Prediabetes as a risk factor for major adverse cardiovascular events
por: Mando, Ramy, et al.
Publicado: (2021)

Trial Sequential Analysis Comparing Bleeding and Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation and Acute Coronary Syndrome on Dual versus Triple Therapy
por: Munir, Muhamad B, et al.
Publicado: (2019)

MACE in the Race: A Canadian Perspective on Major Adverse Cardiac Events (MACE) During Running
por: Abrahim, Mohammed
Publicado: (2022)

Predictive value of three Inflammation-based Glasgow Prognostic Scores for major cardiovascular adverse events in patients with acute myocardial infarction during hospitalization: a retrospective study
por: Zhu, Houyong, et al.
Publicado: (2020)

Risk factors for major adverse cardiovascular events after the first acute coronary syndrome
por: Okkonen, Marjo, et al.
Publicado: (2021)

All-Cause Mortality and Incidence of Major Adverse Cardiac Events in Sickle Cell Nephropathy: A Comparative Study
por: Udani, Kunjan, et al.
Publicado: (2021)

Variety of Cardiac Events in Hospitalized Chronic Kidney Disease Patients
por: Jabbar, Asfia, et al.
Publicado: (2021)

Plasma Homocysteine Levels and Cardiovascular Events in Patients With End-Stage Renal Disease: A Systematic Review
por: ALSolami, Abdulilah A, et al.
Publicado: (2023)

Adverse Events in Primary Percutaneous Coronary Angioplasty With Drug-Eluting Stents Compared With Drug-Coated Balloons: A Retrospective Outlook
por: Sharif Khan, Hamid, et al.
Publicado: (2020)

Multicenter analysis to assess risk of major adverse cardiac events in patients undergoing high‐sensitivity troponin testing in the emergency department
por: Serven, Victoria, et al.
Publicado: (2023)

Erosion of Cardiovascular Implantable Device: Conservative Therapy or Extraction?
por: Tabbah, Randa N, et al.
Publicado: (2020)

Cardiac Adverse Events With Remdesivir in COVID-19 Infection
por: Gupta, Anupam K, et al.
Publicado: (2020)

Knowledge and Attitudes Toward Cardiovascular Diseases and Their Risk Factors Among the Najran Population in Saudi Arabia
por: AlShehri, Hamdan, et al.
Publicado: (2023)

Manipal lifestyle modification score to predict major adverse cardiac events in postcoronary angioplasty patients
por: Devasia, Tom, et al.
Publicado: (2018)

Adverse Effects of Cannabinoids and Tobacco Consumption on the Cardiovascular System: A Systematic Review
por: Abu Jad, Anas A, et al.
Publicado: (2022)

A Systematic Review on the Safety and Efficacy of PCSK9 Inhibitors in Lowering Cardiovascular Risks in Patients With Chronic Kidney Disease
por: Igweonu-Nwakile, Emmanuelar O, et al.
Publicado: (2022)

Cytochrome P450 2C19 Polymorphisms and Its Association With Major Adverse Cardiac Events in Post-coronary Intervention Patients on Clopidogrel in the Tertiary Care Center
por: Kambhampati, Nikhil Teja, et al.
Publicado: (2023)

New Diagnosis of Non-compaction Cardiomyopathy in a 43-Year-Old Man Presenting with Syncope
por: Musmar, Ahmad, et al.
Publicado: (2019)

Gender-specific secondary prevention? Differential psychosocial risk factors for major cardiovascular events
por: Kure, Christina E, et al.
Publicado: (2016)

Baroreflex sensitivity but not microvolt T-wave alternans can predict major adverse cardiac events in ischemic heart failure
por: Kaufmann, Damian K., et al.
Publicado: (2022)

Role of Gut Microbiome in Cardiovascular Events: A Systematic Review
por: Mansuri, Naushad M, et al.
Publicado: (2022)

Under-diagnosis of Takotsubo Cardiomyopathy Increases Risk of Adverse Events: A Case Study
por: Power, Harvinder S
Publicado: (2019)

A Cross-Sectional Study on the Prevalence of Self-Prescribed Aspirin Use for Prevention of Adverse Ischemic Vascular Events Among Moderate-Risk Individuals: A Single Center Study
por: Almulhim, Nasser A, et al.
Publicado: (2023)

Statin Induced Autoimmune Necrotizing Myopathy (SIANM): An Alarming Adverse Event of a Familiar Medication
por: Ganta, Nagapratap, et al.
Publicado: (2022)

Posttraumatic Stress Disorder (PTSD) and Instigation of Cardiovascular Events: Ischemic Heart Disease (IHD) and Atrial Fibrillation (AF)
por: Habbal, Ahmad B, et al.
Publicado: (2022)

Osteoporosis Prevention and Treatment: The Risk of Comorbid Cardiovascular Events in Postmenopausal Women
por: Gilbert, Zachary A, et al.
Publicado: (2022)

Cardiovascular Remodeling in Chronic Mineralocorticoid Excess
por: Bhattad, Pradnya Brijmohan, et al.
Publicado: (2023)

Serious Adverse Events Associated With Hydroxychloroquine Amidst COVID-19 Pandemic: Case Series and Literature Review
por: Abdelmaseih, Ramy, et al.
Publicado: (2020)

A Systematic Review and Meta-Analysis on the Efficacy and Safety of Finerenone Therapy in Patients with Cardiovascular and Chronic Kidney Diseases in Type 2 Diabetes Mellitus
por: Jyotsna, FNU, et al.
Publicado: (2023)

Influence of Lifestyle Changes on Cardiovascular Diseases in Saudi Arabia: A Systematic Literature Review
por: Munawir Alhejely, Mahamad M, et al.
Publicado: (2023)

Sarcopenia and echocardiographic parameters for prediction of cardiovascular events and mortality in patients undergoing maintenance hemodialysis
por: Zhang, Mengyan, et al.
Publicado: (2022)

Efficacy and Safety of Bempedoic Acid to Prevent Cardiovascular Events in Individuals at Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized-Control Trials
por: Krishna Mohan, Gautham Varun, et al.
Publicado: (2023)

COVID-19 Presenting as Major Thromboembolic Events: Virchow’s Triad Revisited and Clinical Considerations of Therapeutic Anticoagulation
por: Zheng, Haoyi, et al.
Publicado: (2020)

Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status
por: Currie, Craig J., et al.
Publicado: (2019)

Atrial Fibrillation in Chronic Kidney Disease: An Overview
por: Gadde, Sai, et al.
Publicado: (2022)

Non-ST-Segment Elevation Myocardial Infarction As Initial Thrombotic Event of Thrombotic Thrombocytopenic Purpura: A Rare Challenging Case
por: Mohamed, Khalid H, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i71akqeas93osfdsounro1ffp2